Oxana Tsygankova

1PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 12, 2024
The FcγRIIIA (CD16) L48-H/R Polymorphism Enhances NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity by Promoting Serial Killing.

Nicholas A Maskalenko, Sam Zahroun, Oxana Tsygankova

Pageof 1

Frequent Collaborators

1 joint publications

Nicholas A Maskalenko

1 joint publications

Sam Zahroun

1 joint publications

Nadia Anikeeva

1 joint publications

Yuri Sykulev